Improving ocular bioavailability of hydrophilic drugs through dynamic covalent complexation
Yan Liu,Ding Chen,Jing-jie Wang,Xin-xin Liu,Chen-chen Zhu,Tian-zuo Wang,Si-yu Wang,Xin-yang Pan,Min-hua Liu,Ling-li Li,Zhi-min Zhou,Kai-hui Nan
DOI: https://doi.org/10.1016/j.jconrel.2023.01.081
IF: 11.467
2023-02-12
Journal of Controlled Release
Abstract:The clinical benefits of diquafosol tetrasodium (DQS), a hydrophilic P2Y2 receptor agonist for dry eye, have been hindered by a demanding dosing regimen. Nevertheless, it is challenging to achieve sustained release of DQS with conventional drug delivery vehicles which are mainly designed for hydrophobic small molecule drugs. To address this, we developed an affinity hydrogel for DQS by taking advantage of borate-mediated dynamic covalent complexation between DQS and hydroxypropyl guar. The resultant formulation (3% DQS Gel) was characterized by sustained release, low corneal permeation, and extended ocular retention, which were desirable attributes for ocular surface drug delivery. Both in vitro and in vivo studies had been carried out to verify the biocompatibility of 3% DQS Gel. Using corneal fluorescein staining, the Schirmer's test, PAS staining, quantitative PCR and immunohistological analyses as outcome measures, the superior therapeutic effects of 3% DQS Gel over PBS, the hydrogel vehicle and free DQS were demonstrated in a mouse dry eye model. Our DQS delivery strategy reported herein is readily applicable to other hydrophilic small molecule drugs with cis -diol moieties, thus providing a general solution to improve clinical outcomes of numerous diseases.
pharmacology & pharmacy,chemistry, multidisciplinary